Language Selector

    Innovative Medicines Initiative (IMI) 2 Indicative Topics for Call 14 out

    Published on 24 January 2018
    Author: Agnes Szeberenyi, National Contact Point Health & ICT

    To give potential applicants as much time as possible to form consortia and prepare their proposals, IMI regularly publishes draft topic texts several weeks before the official call launch.

    The following topics are currently under consideration for inclusion in future IMI calls for proposals for Call 14:

    • Targeted immune intervention for treatment of non-response and remission
    • Non-invasive clinical molecular imaging of immune cells
    • Development of a platform for federated and privacy-preserving machine learning in support of drug discovery
    • Centre of excellence – remote decentralised clinical trials

    SMEs are strongly encourages to participate in IMI2 projects. This presentation highlights elements of the current indicative call topics that could be particularly interesting for SMEs. More information and guidance for SMEs can be found in IMI's dedicated SME section.

    All information regarding future IMI call topics is indicative and subject to change. Final information about future IMI calls will be communicated after approval by the IMI Governing Board.

    More Information